Redvax Company
Redvax is a spin-off from Redbiotec AG, a privately held Swiss biopharmaceutical company, based in Zurich-Schlieren. Redvax is a preclinical stage company. The company develops multi-component virus-like particles (VLPs) and other protein assemblies for vaccine development in the field of CMV and a further undisclosed field.
Headquarters:
Schlieren, Zurich, Switzerland, Europe
Industry:
Vaccines & Immunotherapy
Super Industry:
Biopharma & Life Science Tools
Investors:
redalpine
Ipo Status:
private
City:
Schlieren
Region:
Zurich
Country:
Switzerland